# SBRT/RT in Oligometastatic Stage IV NSCLC

> **NCT05647590** · NA · UNKNOWN · sponsor: **University Hospital Ostrava** · enrollment: 10 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **PROCEDURE:** Chemotherapy
- **PROCEDURE:** Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT)
- **PROCEDURE:** Maintenance chemotherapy

## Key facts

- **NCT ID:** NCT05647590
- **Lead sponsor:** University Hospital Ostrava
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05647590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05647590, "SBRT/RT in Oligometastatic Stage IV NSCLC". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05647590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*